Home › Therapeutic areas › Neurology › Progressive Supranuclear Palsy

Progressive Supranuclear Palsy (2 companies)

Companies with an active program in Progressive Supranuclear Palsy.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
ACIU	AC Immune	Neurology Rare	1	Phase 3	$222M	11
ARVN	Arvinas	NeurologyOncology Rare	1	Approved	$420M	10